Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALVAGE
NCT00284323Phase 2Unknown
- Sponsor
- UZ Leuven
- Start
- Jan 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of adenosine in acute ST elevation myocardial infarction (STEMI) (2 arms), sponsored by UZ Leuven. Primary endpoints: Magnetic Resonance Imaging Parameters at 4 months, Tissue Doppler Imaging Parameters at 4 months and 5 more. Status: unknown.
02
Drugs
adenosine
03
Conditions
acute ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00284323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284323.